Long-Lived Tangible Asset [Axis] Long-Lived Tangible Asset [Axis] Business Acquisition [Axis] Business Acquisition [Axis] Adjustments to reconcile net loss to net cash used in operating activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Total future minimum lease payments Lessee, Operating Lease, Liability, to be Paid Income tax benefit Income tax expense (benefit) Income Tax Expense (Benefit) Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration] Deferred tax liabilities Deferred Income Tax Liabilities, Net Preferred stock, par value (in USD per share) Preferred Stock, Par or Stated Value Per Share 2027 Lessee, Operating Lease, Liability, to be Paid, Year Four Income Statement [Abstract] Income Statement [Abstract] Entity Address, Postal Zip Code Entity Address, Postal Zip Code Additional Paid-in Capital Additional Paid-in Capital [Member] Document Fiscal Period Focus Document Fiscal Period Focus Finance right-of-use assets Finance Lease, Right-of-Use Asset, after Accumulated Amortization Contract manufacturing and testing Biopharmaceutical And Other - Contract Manufacturing And Testing [Member] Biopharmaceutical And Other - Contract Manufacturing And Testing Sale of short-term investments Debt Securities, Held-to-Maturity, Sold at Par Value Cash and Cash Equivalents Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block] Shares used to compute net loss per common share, diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Preferred stock, shares outstanding (in shares) Preferred Stock, Shares Outstanding Finance lease liabilities Finance Lease, Liability Income Tax Disclosure [Abstract] Accounts receivable Accounts Receivable [Member] Other Income and Expenses [Abstract] Common stock, $0.001 par value; 125,000,000 shares authorized, 72,383,140 and 71,959,454 shares issued and outstanding as of March 31, 2023 and December 31, 2022, respectively Common Stock, Value, Issued Investing activities Net Cash Provided by (Used in) Investing Activities, Continuing Operations [Abstract] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Schedule of Other Income, net Schedule of Other Nonoperating Income (Expense) [Table Text Block] Financial Instruments [Domain] Financial Instruments [Domain] Biopharmaceutical and other revenue Biopharmaceutical And Other [Member] Represents biopharmaceutical. Statistical Measurement [Domain] Statistical Measurement [Domain] Schedule of Outstanding Common Stock Equivalents Excluded From Diluted Net Loss Per Common Share Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block] Discount rate Operating Lease, Weighted Average Discount Rate, Percent Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Additional paid-in capital Additional Paid in Capital, Common Stock Cash, cash equivalents and restricted cash at beginning of period Cash, cash equivalents and restricted cash at end of period Total cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Change in currency translation adjustments Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Property, plant and equipment, net Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization Current liabilities: Liabilities, Current [Abstract] Proceeds from the exercise of common stock options and employee stock purchases Proceeds from Stock Options Exercised Common stock, shares issued (in shares) Common Stock, Shares, Issued Net loss Net loss Net loss Net Income (Loss) Attributable to Parent Measurement Input Type [Domain] Measurement Input Type [Domain] Outstanding shares of common stock equivalents that have been excluded from diluted net loss per common share Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Current portion of deferred revenue Contract with Customer, Liability, Current Shares of common stock subject to outstanding options (in shares) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Purchases of property, plant and equipment included in accounts payable and accrued liability Capital Expenditures Incurred but Not yet Paid Effect of foreign currency on operations Foreign Currency Transaction Gain (Loss), before Tax HalioDx customer relationships HalioDx Customer Relationships [Member] HalioDx Customer Relationships Amortized cost of short-term investments sold Debt Securities, Held-to-Maturity, Amortized Cost, after Allowance for Credit Loss, Sold, Amount Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Equity Component [Domain] Equity Component [Domain] Amendment Flag Amendment Flag Weighted Average Remaining Amortization Period (Years) Finite-Lived Intangible Asset, Useful Life Net cash provided by (used in) investing activities Net Cash Provided by (Used in) Investing Activities Discount rate Measurement Input, Discount Rate [Member] Short-Term Investments Investment, Policy [Policy Text Block] Issuance of common stock under ESPP Stock Issued During Period, Value, Employee Stock Purchase Plan Net comprehensive loss Comprehensive Income (Loss), Net of Tax, Attributable to Parent Term of lease Lessee, Operating Lease, Lease Not yet Commenced, Term of Contract Entity Current Reporting Status Entity Current Reporting Status Current portion of other liabilities Other Liabilities, Current Other assets Other Assets, Noncurrent Concentrations of Credit Risk and Other Risks and Uncertainties Concentrations Of Credit And Other Risks And Uncertainties [Policy Text Block] Disclosure of accounting policy for concentrations of credit risk and other risks and uncertainties. Proceeds from maturity of short-term investments Proceeds from Maturities, Prepayments and Calls of Held-to-Maturity Securities Noncash lease expense Noncash Lease Expense The noncash portion of lease expense. Supplementary cash flow information: Supplemental Cash Flow Information [Abstract] Security deposit Security Deposit Depreciation and amortization Depreciation, Depletion and Amortization Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Number of operating segments Number of Operating Segments Lease Contractual Term [Domain] Lease Contractual Term [Domain] Remainder of 2023 Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Entity Address, State or Province Entity Address, State or Province Issuance of common stock under ESPP (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Employee stock purchase plan Employee Stock [Member] Other comprehensive income (loss): Other Comprehensive Income (Loss), Net of Tax [Abstract] Options issued and outstanding (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Award Type [Axis] Award Type [Axis] Schedule of Stock by Class [Table] Schedule of Stock by Class [Table] Net cash used in operating activities Net Cash Provided by (Used in) Operating Activities Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code LymphMark product technology LymphMark Product Technology [Member] Represents LymphMark product technology. Current portion of operating lease liabilities Less: short-term lease liabilities Operating Lease, Liability, Current Accounts, Notes, Loans and Financing Receivable [Line Items] Accounts, Notes, Loans and Financing Receivable [Line Items] Basis of Presentation Basis of Accounting, Policy [Policy Text Block] Effect of foreign currency on cash, cash equivalents and restricted cash Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Accrued liabilities and deferred revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Increase (Decrease) In Accrued Liabilities And Deferred Revenue Cash paid for amounts included in the measurement of lease liabilities Operating Lease, Payments Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Operating Leases, Future Minimum Payments Due, Fiscal Year Maturity [Abstract] Defined Benefit Plan, Type [Extensible List] Defined Benefit Plan, Type [Extensible Enumeration] Payment of long-term debt Repayments of Long-Term Debt Schedule of Future Aggregate Amortization Expense Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Other assets Increase (Decrease) in Other Noncurrent Assets Purchase of short-term investments Payments to Acquire Held-to-Maturity Securities Stock-based compensation expense (non-employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Non Employee Amount of increase In additional paid-in capital (APIC) resulting from non-employee stock-based compensation expense. Other income, net Other income, net Other Nonoperating Income (Expense) Raw materials and finished diagnostic kits Inventory, Work in Process and Raw Materials Stock-based compensation expense (employee) Adjustments To Additional Paid In Capital, Share Based Compensation, Employee Amount of increase in additional paid-in capital (APIC) resulting from employee stock-based compensation expense. Common stock, shares authorized (in shares) Common Stock, Shares Authorized HalioDx developed technology HalioDX Developed Technology [Member] HalioDX Developed Technology Total liabilities Liabilities Weighted average remaining lease term Operating Lease, Weighted Average Remaining Lease Term Statement of Comprehensive Income [Abstract] Maximum Maximum [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Thereafter Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Lessee, Operating Lease, Liability, To Be Paid, Due After Year Four Operating Leases Operating Leased Assets [Line Items] Entity Common Stock, Shares Outstanding (in shares) Entity Common Stock, Shares Outstanding Restricted cash Restricted cash Long term deposit Restricted Cash and Cash Equivalents, Noncurrent Cash and cash equivalents Cash and cash equivalents Cash and Cash Equivalents, at Carrying Value Percepta product technology Percepta Product Technology [Member] Percepta Technology [Member] Total current assets Assets, Current Revenue Recognition and Cost of Revenue Revenue from Contract with Customer [Policy Text Block] Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Document Type Document Type Entity Small Business Entity Small Business Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Balance at beginning of period (in shares) Balance at end of period (in shares) Shares, Outstanding Shares of common stock subject to outstanding options Employee And Non Employee Stock Option [Member] An arrangement whereby an employee or non-employee is entitled to receive in the future, subject to vesting and other restrictions, number of shares in the entity at a specified price, as defined in the agreement. Stockholders' Equity Stockholders' Equity Note Disclosure [Text Block] Revenue: Revenues [Abstract] Total Finite-Lived Intangible Assets, Net Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Customers Representing >10% Of Total Revenue Major Customers [Member] Major Customers Product and Service [Domain] Product and Service [Domain] Operating activities Net Cash Provided by (Used in) Operating Activities, Continuing Operations [Abstract] Entity Shell Company Entity Shell Company Benefit from income taxes Deferred Income Tax Expense (Benefit) Schedule of Third-party Payers as a Percentage of Total Schedules of Concentration of Risk, by Risk Factor [Table Text Block] 2024 Lessee, Operating Lease, Liability, to be Paid, Year One Long-Lived Tangible Asset [Domain] Long-Lived Tangible Asset [Domain] Financial Instrument [Axis] Financial Instrument [Axis] Accounts receivable Increase (Decrease) in Accounts Receivable Title of 12(b) Security Title of 12(b) Security Headquarters And Laboratory Facilities South San Francisco and San Diego, California, Austin, Texas, Marseille, France and Richmond, Virginia Headquarters And Laboratory Facilities South San Francisco And San Diego, California, Austin, Texas, Marseille, France And Richmond, Virginia [Member] Headquarters And Laboratory Facilities South San Francisco And San Diego, California, Austin, Texas, Marseille, France And Richmond, Virginia Finance Lease, Liability, Statement of Financial Position [Extensible List] Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration] Revenue Revenue Benchmark [Member] Headquarters And Laboratory Facilities South San Francisco Headquarters And Laboratory Facilities South San Francisco [Member] Headquarters And Laboratory Facilities South San Francisco Document Period End Date Document Period End Date Total operating expenses Costs and Expenses Class of Stock [Line Items] Class of Stock [Line Items] Present value of future lease payments Operating Lease, Liability Total assets Assets Earnings Per Share [Abstract] Schedule of Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] 2025 Finite-Lived Intangible Asset, Expected Amortization, Year Two Antidilutive Securities [Axis] Antidilutive Securities [Axis] Thereafter Finite-Lived Intangible Asset, Expected Amortization, After Year Four Finite-Lived Intangible Asset, Expected Amortization, After Year Four Liabilities and Stockholders’ Equity Liabilities and Equity [Abstract] Accrued liabilities Total accrued liabilities Accrued Liabilities, Current Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Net cash provided by financing activities Net Cash Provided by (Used in) Financing Activities Supplies and inventory Inventory, Net Accrued compensation expenses Employee-related Liabilities, Current HalioDx customer backlog HalioDx Customer Backlog [Member] HalioDx Customer Backlog Accounts payable Accounts Payable, Current Loss before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Stockholders’ equity: Stockholders' Equity Attributable to Parent [Abstract] Prepaid expenses and other current assets Prepaid Expense and Other Assets, Current Proceeds from sale of short-term investments Proceeds from Sale of Held-to-Maturity Securities Net Loss Per Common Share Earnings Per Share [Text Block] Customer [Axis] Customer [Axis] French research tax credits Other Nonoperating Income (Expense), Foreign Tax Credit Foreign Tax Credit, Nonoperating Balance Sheet Components Supplemental Balance Sheet Disclosures [Text Block] Operating lease liabilities Increase (Decrease) in Operating Lease Liability Entity Filer Category Entity Filer Category Shares used to compute net loss per common share, basic (in shares) Weighted Average Number of Shares Outstanding, Basic Award Type [Domain] Award Type [Domain] Short-term investments Debt Securities, Held-to-Maturity, Excluding Accrued Interest, after Allowance for Credit Loss Lab supplies and reagents consumed Inventory, Finished Goods, Gross Commitments and contingencies Commitments and Contingencies Financing activities Net Cash Provided by (Used in) Financing Activities, Continuing Operations [Abstract] Security Exchange Name Security Exchange Name Entity Registrant Name Entity Registrant Name Other Other Nonoperating Income (Expense), Other Other Nonoperating Income (Expense), Other Interest income Other Nonoperating Income (Expense), Interest Income Other Nonoperating Income (Expense), Interest Income Preferred stock, $0.001 par value; 5,000,000 shares authorized, no shares issued and outstanding as of March 31, 2023 and December 31, 2022 Preferred Stock, Value, Issued Decipher product technology Decipher BioSciences Product Technology [Member] Decipher BioSciences Product Technology Short-term investments, allowance for expected credit losses Debt Securities, Held-to-Maturity, Allowance for Credit Loss, Excluding Accrued Interest Total revenue Revenue from Contract with Customer, Excluding Assessed Tax Entity Address, City or Town Entity Address, City or Town Schedule of Operating Leased Assets [Table] Schedule of Operating Leased Assets [Table] Value of shares issued in acquisition Business Combination, Consideration Transferred, Equity Interests Issued and Issuable Total number of shares reserved for issuance (in shares) Common Stock, Capital Shares Reserved for Future Issuance Issuance of common stock on exercise of stock options and vesting of restricted stock units (in shares) Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Options And Non-Option Equity Instruments, Exercises In Period Operating expenses: Operating Expenses [Abstract] Cover [Abstract] Cover [Abstract] Additional cash to be paid Business Combination, Contingent Consideration, Cash To Be Paid Business Combination, Contingent Consideration, Cash To Be Paid Minimum Minimum [Member] Short-term investments, fair value Debt Securities, Held-to-Maturity, Fair Value Stock-based compensation expense (ESPP) Adjustments To Additional Paid In Capital, Share Based Compensation, ESPP Amount of increase in additional paid-in capital (APIC) resulting from ESPP stock-based compensation expense. Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Common stock, par value (in USD per share) Common Stock, Par or Stated Value Per Share Commitments and Contingencies Disclosure [Abstract] nCounter Dx license nCounter Dx License [Member] nCounter Dx License [Member] Fair Value Measurements Fair Value Disclosures [Text Block] Decipher trade names Decipher Biosciences Trade Names [Member] Decipher Biosciences Trade Names Payment of taxes on vested restricted stock units Payment, Tax Withholding, Share-Based Payment Arrangement Total liabilities and stockholders’ equity Liabilities and Equity Trading Symbol Trading Symbol Entity File Number Entity File Number Interest on end-of-term debt obligation Debt Instrument, End Of Term Payment Interest Amount And Prepayment Penalty Debt Instrument, End Of Term Payment Interest Amount And Prepayment Penalty Gain (loss) on currency revaluation Other Nonoperating Income (Expense), Foreign Currency Translation Gain (Loss) Foreign Currency Translation Gain (Loss), Nonoperating 2027 Finite-Lived Intangible Asset, Expected Amortization, Year Four Research and development Research and Development Expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Restricted stock units Restricted Stock Units (RSUs) [Member] Current Fiscal Year End Date Current Fiscal Year End Date Prosigna customer relationships Prosigna Customer Relationships [Member] Represents Prosigna customer relationships. Concentration Risk Benchmark [Axis] Concentration Risk Benchmark [Axis] Less: amount representing interest Lessee, Operating Lease, Liability, Undiscounted Excess Amount Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Net loss per common share, diluted (in USD per share) Earnings Per Share, Diluted Intangible assets, net Intangible assets, net Intangible Assets, Net (Excluding Goodwill) Use of Estimates Use of Estimates, Policy [Policy Text Block] Components of Other Income Other Nonoperating Income and Expense [Text Block] Cash and cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Accounts payable Increase (Decrease) in Accounts Payable Loss on disposal of property, plant and equipment Gain (Loss) on Disposition of Property Plant Equipment Schedule of Reserved Shares of Common Stock for Issuance Schedule of Stock by Class [Table Text Block] Concentration risk Concentration Risk, Percentage Probability of achievement Measurement Input, Probability Of Achievement [Member] Measurement input using probability of achievement. Concentration Risk Type [Axis] Concentration Risk Type [Axis] Total current liabilities Liabilities, Current 2025 Lessee, Operating Lease, Liability, to be Paid, Year Two Income Taxes Income Tax Disclosure [Text Block] Customer concentration risk Customer Concentration Risk [Member] NanoString NanoString [Member] Represents NanoString. Total intangible assets Intangible Assets, Gross (Excluding Goodwill) Intangible asset amortization Amortization of Intangible Assets Net loss per common share, basic (in USD per share) Earnings Per Share, Basic 2026 Lessee, Operating Lease, Liability, to be Paid, Year Three Medicare Medicare [Member] Represents Medicare. Schedule of Future Minimum Lease Payments Under Non-cancelable Operating Leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Entity Address, Address Line Two Entity Address, Address Line Two Testing revenue Testing [Member] Represents testing. Entity Address, Address Line One Entity Address, Address Line One Concentration Risk Type [Domain] Concentration Risk Type [Domain] Cost of revenue Cost of Revenue Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Schedule of Accounts, Notes, Loans and Financing Receivable [Table] Deferred revenue Contract with Customer, Liability Selling and marketing Selling and Marketing Expense Total stockholders’ equity Balance at beginning of period Balance at end of period Stockholders' Equity Attributable to Parent Product and Service [Axis] Product and Service [Axis] Issuance of common stock on exercise of stock options and vesting of restricted stock units Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Share-Based Compensation Arrangement By Share-Based Payment Award, Value, Options And Non-Option Equity Instruments, Exercises In Period Lease Contractual Term [Axis] Lease Contractual Term [Axis] Equity Interest Issued or Issuable, Type [Domain] Equity Interest Issued or Issuable, Type [Domain] Fair Value Disclosures [Abstract] Entity Interactive Data Current Entity Interactive Data Current Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Facilities in Marseille, France Facilities In Marseille, France [Member] Facilities In Marseille, France Changes in operating assets and liabilities: Increase (Decrease) in Operating Capital [Abstract] 2026 Finite-Lived Intangible Asset, Expected Amortization, Year Three Schedule of Accrued Liabilities Schedule of Accrued Liabilities [Table Text Block] Money Market Funds Money Market Funds [Member] Equity [Abstract] Accumulated Deficit Retained Earnings [Member] Entity Tax Identification Number Entity Tax Identification Number Increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Common Stock Common Stock [Member] Other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Schedule of Operating Lease Expense and Measurement Of Lease Liabilities Lease, Cost [Table Text Block] Shares available for issuance (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Number of Shares Available for Grant Acquisition-related contingent consideration, net of current portion Business Combination, Contingent Consideration, Liability Statement [Table] Statement [Table] Schedule of Revenue Disaggregation of Revenue [Table Text Block] 2023 remainder of year Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year Document Quarterly Report Document Quarterly Report Current assets: Assets, Current [Abstract] Operating lease liabilities, net of current portion Long-term lease liabilities Operating Lease, Liability, Noncurrent Fair Value Measurement Inputs and Valuation Techniques Fair Value Measurement Inputs and Valuation Techniques [Table Text Block] Statistical Measurement [Axis] Statistical Measurement [Axis] Net increase (decrease) in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Accumulated deficit Retained Earnings (Accumulated Deficit) Measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Equity Interest Type [Axis] Equity Interest Type [Axis] Accounts receivable Accounts Receivable, after Allowance for Credit Loss, Current Schedule of Finite-Lived Intangible Assets [Table] Schedule of Finite-Lived Intangible Assets [Table] Entity Central Index Key Entity Central Index Key Antidilutive Securities, Name [Domain] Antidilutive Securities, Name [Domain] Equity Components [Axis] Equity Components [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Tax portion of vested restricted stock units Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation Cash paid in acquisition Business Combination, Consideration Transferred Interest expense Other Nonoperating Income (Expense), Interest Expense Interest Expense, Nonoperating Accrued other Other Accrued Liabilities, Current Measurement Input Type [Axis] Measurement Input Type [Axis] Document Fiscal Year Focus Document Fiscal Year Focus City Area Code City Area Code General and administrative General and Administrative Expense Statement [Line Items] Statement [Line Items] Assets Assets [Abstract] Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Table] Current portion of acquisition-related contingent consideration Short term contingent considerations Business Combination, Contingent Consideration, Liability, Current Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Gross Carrying Amount Finite-Lived Intangible Assets, Gross Revaluation of acquisition-related contingent consideration Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability Product revenue Product [Member] Right-of-use assets, operating leases Operating Lease, Right-of-Use Asset Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Organization, Description of Business and Summary of Significant Accounting Policies Business Description and Accounting Policies [Text Block] Stock-based compensation Share-Based Payment Arrangement, Noncash Expense Other liabilities Other Liabilities, Noncurrent Operating lease expense Operating Lease, Expense Document Transition Report Document Transition Report Local Phone Number Local Phone Number Realized gains (losses) from sale of short-term investments Debt Securities, Held-to-Maturity, Sold, Realized Gain (Loss), Excluding Other-than-temporary Impairment Prosigna product technology Developed Product Technology [Member] Developed Product Technology Purchases of property, plant and equipment Payments to Acquire Property, Plant, and Equipment Impairment loss Asset Impairment Charges Loss from operations Operating Income (Loss) Annual rent Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Lessee, Operating Lease, Lease Not Yet Commenced, Annual Undiscounted Amount Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Supplies and inventory Increase (Decrease) in Inventories Weighted Average Weighted Average [Member] Recent Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] 2024 Finite-Lived Intangible Asset, Expected Amortization, Year One UnitedHealthcare United Healthcare [Member] Represents United Healthcare. Pension obligation Defined Benefit Plan, Benefit Obligation Biopharmaceutical revenue Biopharmaceutical And Other - Biopharmaceutical Revenue [Member] Biopharmaceutical And Other - Biopharmaceutical Revenue Prepaid expenses and other current assets Increase (Decrease) in Prepaid Expense and Other Assets Pension Liability Pension and Other Postretirement Plans, Pensions, Policy [Policy Text Block] Common stock, shares outstanding (in shares) Common Stock, Shares, Outstanding Contingent consideration, changes in fair value Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Business Combination, Contingent Consideration, Liability, Fair Value Adjustment Goodwill Goodwill Customer [Domain] Customer [Domain] Balance Sheet Related Disclosures [Abstract] Pension Plan [Member]